PBM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Psyence Biomedical partners with Benuvia Operations to establish U.S. manufacturing of pharmaceutical-grade ibogaineOct 5, 2026
- Psyence BioMed started patient dosing in the Phase 2b trial of NPX-5 for adjustment disorderApr 23, 2026
- Psyence BioMed exported GMP-manufactured natural psilocybin (NPX-5) to Australia for its ongoing Phase IIb trialMar 4, 2026
- Psyence BioMed reached a major breakthrough in pharmaceutical-grade ibogaine supply for worldwide clinical and therapeutic marketsNov 20, 2025
- Psyence BioMed establishes ibogaine operations in Africa through a strategic investment in PsyLabsNov 12, 2025